(Date:11/20/2009)...NGTON, Nov. 20 The Ame...o modify health care reform legislation released t...health insurance individual coverage mandate. The ...andate will minimize adverse selection stemming fr...bed by the bill. ,, "The individual mandate lan...
(Date:11/20/2009)...SON, N.J., Nov. 20 Rates... have peaked in late October, but the pandemic flu...ss in all age groups, including the elderly, accor...ated (NYSE: DGX ), the world,s leading provider ...,, In its most recent Quest Diagnostics Health ...
(Date:11/20/2009)...-SALEM, N.C., Nov. 20 S...on to redefine what it means to be "happy" during ... with a specialty in family counseling and chair o...ersity, Gladding says research shows that it is th... and even depression during the holidays. ,, Th...
(Date:11/20/2009)...f exposure to formaldehyde used for embalming in t...sed risk of death from myeloid leukemia, according...e Journal of the National Cancer Institute . , ...lymphohematopoietic malignancies and brain cancer ...workers, all of whom may have worked with formalde...
(Date:11/20/2009)... as short as 34 weeks, potentially adding to preem..., Nov. 20 (HealthDay News) -- Recent reports show ...limb in the United States. Now, a new study sugge...what constitutes a full-term birth in the first pl...d in the study considered a baby born at 34 to 36 ...
Breaking Medicine News(10 mins):Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2Health News:Many Women Miscalculate Time to Full-Term Birth 2Health News:Many Women Miscalculate Time to Full-Term Birth 3Health News:Many Women Miscalculate Time to Full-Term Birth 4(Date:11/20/2009)..., MINNEAPOLIS, Nov. 20 ...results for its first quarter ended September 30, ...iluted share, on revenues of $3,263,000. This com...luted share, on revenues of $3,168,000 for the fir...irst quarter results, Biotel President and CEO Ste...
(Date:11/20/2009)..., FRANKLIN LAKES, N.J., Nov. 20 /PRNewswire-Fir...E: BDX ) today announced the completion of its a...an-based company that develops and manufactures mo.... ,, In May 2009, BD and HandyLab announced an ...alize molecular assays on the HandyLab Jaguar(TM) ...
(Date:11/19/2009)... , ARDEE, Ireland, Nov. 19 Warn...he pricing of its previously announced secondary o...price to the public of $22.25 per share. The sell...n Capital Partners, DLJ Merchant Banking, J.P. Mor...H. Lee Partners, L.P., certain other institutional...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4Growing Supply Chain Complexity Increasing Impact on Medical Device Company Operations 5442 1Growing Supply Chain Complexity Increasing Impact on Medical Device Company Operations 5442 2Growing Supply Chain Complexity Increasing Impact on Medical Device Company Operations 5442 3BIOSAFE Launching In a New Specially Treated Facemask Effective Against H1N1 Influenza 5438 1BIOSAFE Launching In a New Specially Treated Facemask Effective Against H1N1 Influenza 5438 2BIOSAFE Launching In a New Specially Treated Facemask Effective Against H1N1 Influenza 5438 3BIOSAFE Launching In a New Specially Treated Facemask Effective Against H1N1 Influenza 5438 4Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR 28R 29 5434 1Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR 28R 29 5434 2Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR 28R 29 5434 3...CO, Calif., March 26 Poniard,Pharmaceuticals, Inc...cused,on oncology, announced an agreement with W. ... supply of picoplatin active pharmaceutical,ingred...he Company,s lead,product candidate, in four clini...trial in small cell lung cancer, and is developing...
...ts collaborate with UBC to provide best science av...s cutting-edge,thinking in study methodology for C...UBC) announces the formation of a European Advisor...established to support UBC in its,ongoing efforts ... that,rely on subjective measurements as pivotal e...
Other Medicine Technology:Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin 2Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin 3UBC Forms European Advisory Board to Enhance Data Quality of CNS Trials 2UBC Forms European Advisory Board to Enhance Data Quality of CNS Trials 3...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: